Tilray Brands (NASDAQ:TLRY) Trading 1.6% Higher – Should You Buy?

Tilray Brands, Inc. (NASDAQ:TLRY)’s share price traded up 1.6% during mid-day trading on Thursday . The company traded as high as $9.21 and last traded at $9.13. 7,699,421 shares changed hands during mid-day trading, an increase of 23% from the average session volume of 6,279,894 shares. The stock had previously closed at $8.99.

Trending Headlines about Tilray Brands

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Record revenue, improved balance sheet — Tilray reported record Q2 net revenue of ~$218M, highlighted strong growth in international medical (+36%) and incremental gains in Canadian adult‑use, and said it moved to a net cash position with ~$292M in cash & marketable securities. Management reaffirmed full‑year adjusted EBITDA guidance, which supports upside to valuation if execution continues. Read More.
• Positive Sentiment: Revenue beat consensus — Reported revenue (~$217.5M) exceeded analyst estimates (~$211M), which helped push the stock higher amid proof of top‑line momentum and better-than-expected demand dynamics. Read More.
• Neutral Sentiment: Earnings call context and strategy — Transcripts and highlights show management emphasizing CPG and international medical expansion, potential opportunities from anticipated U.S. federal cannabis rescheduling, and strategic priorities for margin improvement; these are longer‑term catalysts but will require execution. Read More.
• Negative Sentiment: GAAP EPS miss and weak profitability — Tilray reported ($0.41) EPS vs. consensus of ($0.14), and the company still posts a deeply negative net margin and negative ROE, which keeps near‑term profitability concerns front and center for investors. Read More.
• Negative Sentiment: Analyst price‑target cut — Alliance Global halved its price target on TLRY, a signal that some sell‑side analysts are lowering near‑term expectations; such revisions can amplify downside pressure even after a revenue beat. Read More.

Analyst Ratings Changes

TLRY has been the topic of a number of research analyst reports. Atb Cap Markets upgraded shares of Tilray Brands from a “strong sell” rating to a “hold” rating in a report on Wednesday, December 10th. Wall Street Zen raised Tilray Brands from a “strong sell” rating to a “hold” rating in a research report on Saturday, October 11th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Tilray Brands in a report on Wednesday, October 8th. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Tilray Brands has a consensus rating of “Hold” and an average target price of $20.00.

Tilray Brands Stock Up 0.5%

The firm’s 50-day moving average price is $10.10 and its 200-day moving average price is $10.54. The company has a debt-to-equity ratio of 0.15, a current ratio of 2.62 and a quick ratio of 1.56. The company has a market cap of $1.03 billion, a price-to-earnings ratio of -0.42 and a beta of 1.77.

Tilray Brands (NASDAQ:TLRY) last announced its quarterly earnings results on Thursday, January 8th. The company reported ($0.41) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.27). Tilray Brands had a negative return on equity of 6.05% and a negative net margin of 251.69%.The business had revenue of $217.51 million for the quarter, compared to analysts’ expectations of $211.15 million. During the same period last year, the company posted ($0.03) earnings per share. Sell-side analysts forecast that Tilray Brands, Inc. will post -0.2 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in TLRY. Integrated Wealth Concepts LLC increased its holdings in Tilray Brands by 33.8% in the third quarter. Integrated Wealth Concepts LLC now owns 36,977 shares of the company’s stock valued at $64,000 after buying an additional 9,341 shares during the last quarter. CreativeOne Wealth LLC grew its position in shares of Tilray Brands by 12.2% in the 3rd quarter. CreativeOne Wealth LLC now owns 87,134 shares of the company’s stock worth $151,000 after acquiring an additional 9,452 shares in the last quarter. Dudley Capital Management LLC grew its position in shares of Tilray Brands by 73.3% in the 3rd quarter. Dudley Capital Management LLC now owns 26,000 shares of the company’s stock worth $45,000 after acquiring an additional 11,000 shares in the last quarter. Arizona State Retirement System increased its holdings in shares of Tilray Brands by 4.3% in the 3rd quarter. Arizona State Retirement System now owns 307,193 shares of the company’s stock valued at $531,000 after acquiring an additional 12,675 shares during the last quarter. Finally, Brighton Jones LLC raised its position in shares of Tilray Brands by 28.3% during the 3rd quarter. Brighton Jones LLC now owns 59,510 shares of the company’s stock valued at $103,000 after acquiring an additional 13,137 shares in the last quarter. 9.35% of the stock is owned by institutional investors and hedge funds.

Tilray Brands Company Profile

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.